Human immunodeficiency virus and viral hepatitis among high-risk groups: Understanding the knowledge gap in the Middle East and North Africa Region

World Journal of Hepatology

Volumn 7, Issue 25, 2015, Pages 2619-2630

  Melhem, Nada M ^a   Rahhal, Nour ^a   Charide, Rana ^a   Kreidieh, Khalil ^a   El Khatib, Rolla ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Female sex workers; Hepatitis B virus; Hepatitis C virus; Human immunodeficiency virus; Injecting drug users; Men who have sex with men; Prisoners

Indexed keywords

EID: 84947433788     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v7.i25.2619     Document Type: Review

References (84)

1. Fact Sheet 2014. [Internet] 2014. Available from: URL: http://www.unaids.org/sites/default/files/en/media/unaids/contentassets/documents/factsheet/2014/20140716_FactSheet_en.pdf
2. Ioannou GN, Bryson CL, Weiss NS, Miller R, Scott JD, Boyko EJ. The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodeficiency virus infection. Hepatology 2013; 57: 249-257 [PMID: 22532055 DOI: 10.1002/hep.25800]
3. Matthews PC, Geretti AM, Goulder PJ, Klenerman P. Epidemiology and impact of HIV coinfection with hepatitis B and hepatitis C viruses in Sub-Saharan Africa. J Clin Virol 2014; 61: 20-33 [PMID: 24973812 DOI: 10.1016/j.jcv.2014.05.018]
4. World Health Organization. Hepatitis B 2015 Fact Sheet. Available from: URL: http://www.who.int/mediacentre/factsheets/fs204/en/
5. Kourtis AP, Bulterys M, Hu DJ, Jamieson DJ. HIV-HBV coinfection--a global challenge. N Engl J Med 2012; 366: 1749-1752 [PMID: 22571198 DOI: 10.1056/NEJMp1201796]
6. World Health Organization. Hepatitis C 2014. Available from: URL: http://www.who.int/mediacentre/factsheets/fs164/en/
7. World Health Organization (WHO)-Regional Office for Eastern Mediterranean Region. The growing threats of hepatitis B and C in the Eastern Mediterranean Region: a call for action 2009. Available from: URL: http://applications.emro.who.int/docs/EM_RC56_3_en.pdf
8. Centers for Disease Controal and prevention (CDC). Viral Hepatitis 2015. Available from: URL: http://www.cdc.gov/hepatitis/
9. Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, Kowdley KV. Global epidemiology of hepatitis B virus. J Clin Gastroenterol 2004; 38: S158-S168 [PMID: 15602165]
10. World Health Organization. Guidance on prevention of Viral Hepatitis B and C among people who inject drugs. 2012: 1-46 Available from: URL: http://apps.who.int/iris/bitstream/10665/75357/1/9789241504041_eng.pdf
11. Petty LA, Steinbeck JL, Pursell K, Jensen DM. Human immunodeficiency virus and coinfection with hepatitis B and C. Infect Dis Clin North Am 2014; 28: 477-499 [PMID: 25151567]
12. Thio CL. Hepatitis B and human immunodeficiency virus coinfection. Hepatology 2009; 49: S138-S145 [PMID: 19399813 DOI: 10.1002/hep.22883]
13. Alter MJ. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol 2006; 44: S6-S9 [PMID: 16352363 DOI: 10.1016/j.jhep.2005.11.004]
14. Mohamed HI, Saad ZM, Abd-Elreheem EM, Abd-ElGhany WM, Mohamed MS, Abd Elnaeem EA, Seedhom AE. Hepatitis C, hepatitis B and HIV infection among Egyptian prisoners: seroprevalence, risk factors and related chronic liver diseases. J Infect Public Health 2013; 6: 186-195 [PMID: 23668463 DOI: 10.1016/j.jiph.2012.12.003]
15. Ataie M, Nokhodian Z, Ataei B, Kassaian N, Yaran M, Hassannejad R. Seroprevalence of hepatitis B virus and human immunodeficiency virus among young prisoners. J Res Med Sci 2013; 18: 70-72 [PMID: 23900503]
16. Mir-Nasseri MM, Mohammadkhani A, Tavakkoli H, Ansari E, Poustchi H. Incarceration is a major risk factor for blood-borne infection among intravenous drug users: Incarceration and blood borne infection among intravenous drug users. Hepat Mon 2011; 11: 19-22 [PMID: 22087111]
17. Azarkar Z, Sharifzadeh G. Evaluation of the Prevalence of Hepatitis B, Hepatitis C, and HIV in Inmates with Drug-Related Convictions in Birjand, Iran in 2008. Hepat Mon 2010; 10: 26-30 [PMID: 22308122]
18. Nokhodian Z, Yazdani MR, Yaran M, Shoaei P, Mirian M, Ataei B, Babak A, Ataie M. Prevalence and Risk Factors of HIV, Syphilis, Hepatitis B and C Among Female Prisoners in Isfahan, Iran. Hepat Mon 2012; 12: 442-447 [PMID: 23008724 DOI: 10.5812/hepatmon.6144]
19. Davoodian P, Dadvand H, Mahoori K, Amoozandeh A, Salavati A. Prevalence of selected sexually and blood-borne infections in Injecting drug abuser inmates of bandar abbas and roodan correction facilities, Iran, 2002. Braz J Infect Dis 2009; 13: 356-358 [PMID: 20428635 DOI: 10.1590/s1413-86702009000500008]
20. Asl RT, Eshrati B, Dell CA, Taylor K, Afshar P, Kamali M, Mirzazadeh A. Outcome assessment of a triangular clinic as a harm reduction intervention in Rajaee-Shahr Prison, Iran. Harm Reduct J 2013; 10: 41 [PMID: 24369092 DOI: 10.1186/1477-7517-10-41]
21. Mahfoud Z, Kassak K, Kreidieh K, Shamra S, Ramia S. Prevalence of antibodies to human immunodeficiency virus (HIV), hepatitis B and hepatitis C and risk factors in prisoners in Lebanon. J Infect Dev Ctries 2010; 4: 144-149 [PMID: 20351454]
22. Ziglam H, Zorgani AA, Balouz A, Abudher AH, Elahmer O. Prevalence of antibodies to human immunodeficiency virus, hepatitis B, and hepatitis C in prisoners in Libya. Libyan J Med 2012; 7: 19713 [PMID: 23259007 DOI: 10.3402/ljm.v7i0.19713]
23. Kassak K, Mahfoud Z, Kreidieh K, Shamra S, Afifi R, Ramia S. Hepatitis B virus and hepatitis C virus infections among female sex workers and men who have sex with men in Lebanon: prevalence, risk behaviour and immune status. Sex Health 2011; 8: 229-233 [PMID: 21592438 DOI: 10.1071/sh10080]
24. Valadez JJ, Berendes S, Jeffery C, Thomson J, Ben Othman H, Danon L, Turki AA, Saffialden R, Mirzoyan L. Filling the Knowledge Gap: Measuring HIV Prevalence and Risk Factors among Men Who Have Sex with Men and Female Sex Workers in Tripoli, Libya. PLoS One 2013; 8: e66701 [PMID: 23840521 DOI: 10.1371/journal.pone.0066701]
25. Gul U, Kiliç A, Sakizligil B, Aksaray S, Bilgili S, Demirel O, Erinckan C. Magnitude of sexually transmitted infections among female sex workers in Turkey. J Eur Acad Dermatol Venereol 2008; 22: 1123-1124 [PMID: 18194239 DOI: 10.1111/j.1468-3083.2007.02548.x]
26. Heckathorn D. Respondent Driven Sampling 2012. Available from: URL: http://www.respondentdrivensampling.org/
27. Demetriou VL, van de Vijver DA, Hezka J, Kostrikis LG, Kostrikis LG. Hepatitis C infection among intravenous drug users attending therapy programs in Cyprus. J Med Virol 2010; 82: 263-270 [PMID: 20029809 DOI: 10.1002/jmv.21690]
28. Zamani S, Ichikawa S, Nassirimanesh B, Vazirian M, Ichikawa K, Gouya MM, Afshar P, Ono-Kihara M, Ravari SM, Kihara M. Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran. Int J Drug Policy 2007; 18: 359-363 [PMID: 17854723 DOI: 10.1016/j.drugpo.2007.02.007]
29. Hosseini M, SeyedAlinaghi S, Kheirandish P, Esmaeli Javid G, Shirzad H, Karami N, Jahani M, Seyed Ahmadian M, Payvarmehr F, Mohraz M, Emadi Koochak H, McFarland W. Prevalence and correlates of co-infection with human immunodeficiency virus and hepatitis C virus in male injection drug users in Iran. Arch Iran Med 2010; 13: 318-323 [PMID: 20597566]
30. Eskandarieh S, Nikfarjam A, Tarjoman T, Nasehi A, Jafari F, Saberi-Zafarghandi MB. Descriptive Aspects of Injection Drug Users in Iran's National Harm Reduction Program by Methadone Maintenance Treatment. Iran J Public Health 2013; 42: 588-593 [PMID: 23967426]
31. Honarvar B, Odoomi N, Moghadami M, Afsar Kazerooni P, Hassanabadi A, Zare Dolatabadi P, Farzanfar E, Lankarani KB. Blood-borne hepatitis in opiate users in iran: a poor outlook and urgent need to change nationwide screening policy. PLoS One 2013; 8: e82230 [PMID: 24312645 DOI: 10.1371/journal.pone.0082230]
32. Zamani S, Radfar R, Nematollahi P, Fadaie R, Meshkati M, Mortazavi S, Sedaghat A, Ono-Kihara M, Kihara M. Prevalence of HIV/HCV/HBV infections and drug-related risk behaviours amongst IDUs recruited through peer-driven sampling in Iran. Int J Drug Policy 2010; 21: 493-500 [PMID: 20483578 DOI: 10.1016/j.drugpo.2010.04.006]
33. Rahimi-Movaghar A, Razaghi EM, Sahimi-Izadian E, Amin-Esmaeili M. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran. Int J Infect Dis 2010; 14: e28-e33 [PMID: 19464218 DOI: 10.1016/j.ijid.2009.03.002]
34. Ramezani A, Amirmoezi R, Volk JE, Aghakhani A, Zarinfar N, McFarland W, Banifazl M, Mostafavi E, Eslamifar A, Sofian M. HCV, HBV, and HIV seroprevalence, coinfections, and related behaviors among male injection drug users in Arak, Iran. AIDS Care 2014; 26: 1122-1126 [PMID: 24499303 DOI: 10.1080/09540121.2014.882485]
35. Alipour A, Haghdoost AA, Sajadi L, Zolala F. HIV prevalence and related risk behaviours among female partners of male injecting drugs users in Iran: results of a bio-behavioural survey, 2010. Sex Transm Infect 2013; 89 Suppl 3: iii41-iii44 [PMID: 24064986 DOI: 10.1136/sextrans-2013-051201]
36. Sofian M, Aghakhani A, Banifazl M, Azadmanesh K, Farazi AA, McFarland W, Eslamifar A, Ramezani A. Viral hepatitis and HIV infection among injection drug users in a central Iranian City. J Addict Med 2012; 6: 292-296 [PMID: 22895463 DOI: 10.1097/ADM.0b013e3182659928]
37. Javadi A, Ataei B, Kassaian N, Nokhodian Z, Yaran M. Coinfection of human immunodeficiency virus, hepatitis C and hepatitis B virus among injection drug users in Drop in centers. J Res Med Sci 2014; 19: S17-S21 [PMID: 25002888]
38. Sharif M, Sherif A, Sayyah M. Frequency of HBV, HCV and HIV infections among hospitalized injecting drug users in Kashan. Indian J Sex Transm Dis 2009; 30: 28-30 [PMID: 21938111 DOI: 10.4103/0253-7184.55477]
39. Salehi A, Naghshvarian M, Marzban M, Bagheri Lankarani K. Prevalence of HIV, HCV, and High-Risk Behaviors for Substance Users in Drop in Centers in Southern Iran. J Addict Med 2015; 9: 181-187 [PMID: 25748560 DOI: 10.1097/adm.0000000000000112]
40. Loebstein R, Mahagna R, Maor Y, Kurnik D, Elbaz E, Halkin H, Olchovsky D, Ezra D, Almog S. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors. Isr Med Assoc J 2008; 10: 775-778 [PMID: 19070285]
41. Mirzoyan L, Berendes S, Jeffery C, Thomson J, Ben Othman H, Danon L, Turki AA, Saffialden R, Valadez JJ. New evidence on the HIV epidemic in Libya: why countries must implement prevention programs among people who inject drugs. J Acquir Immune Defic Syndr 2013; 62: 577-583 [PMID: 23337363 DOI: 10.1097/QAI.0b013e318284714a]
42. Stulhofer A, Chetty A, Rabie RA, Jwehan I, Ramlawi A. The prevalence of HIV, HBV, HCV, and HIV-related risk-taking behaviors among Palestinian injecting drug users in the East Jerusalem Governorate. J Urban Health 2012; 89: 671-676 [PMID: 22674463 DOI: 10.1007/s11524-012-9672-z]
43. Alzahrani AJ. Simultaneous detection of hepatitis C virus core antigen and antibodies in Saudi drug users using a novel assay. J Med Virol 2008; 80: 603-606 [PMID: 18297713 DOI: 10.1002/jmv.21075]
44. Mahfoud Z, Kassak K, Kreidieh K, Shamra S, Ramia S. Distribution of hepatitis C virus genotypes among injecting drug users in Lebanon. Virol J 2010; 7: 96 [PMID: 20465784 DOI: 10.1186/1743-422x-7-96]
45. Slesnick N, Glassman M, Garren R, Toviessi P, Bantchevska D, Dashora P. How to open and sustain a drop-in center for homeless youth. Child Youth Serv Rev 2008; 30: 727-734 [PMID: 18584064 DOI: 10.1016/j.childyouth.2007.12.004]
46. Mathers BM, Degenhardt L, Ali H, Wiessing L, Hickman M, Mattick RP, Myers B, Ambekar A, Strathdee SA. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet 2010; 375: 1014-1028 [PMID: 20189638 DOI: 10.1016/s0140-6736(10)60232-2]
47. Des Jarlais DC, Feelemyer JP, Modi SN, Abdul-Quader A, Hagan H. High coverage needle/syringe programs for people who inject drugs in low and middle income countries: a systematic review. BMC Public Health 2013; 13: 53 [PMID: 23332005 DOI: 10.1186/1471-2458-13-53]
48. Center for Disease Management Ministry of Health. Current statistics on HIV/AIDS infection in the Islamic Republic of Iran 2007. Edited by the Iranian Ministry of Health, Tehran, Iran, 2007: 6
49. Khorvash F, Javadi A, Tayeri K, Ataei B. Occult hepatitis B virus infection among human immunodeficiency virus-infected patients with isolated hepatitis B core antibody in Isfahan, Iran. J Res Med Sci 2014; 19: S64-S66 [PMID: 25002898]
50. Alipour A, Rezaianzadeh A, Hasanzadeh J, Rajaeefard A, Davarpanah MA. Sexual Transmission of Hepatitis C Virus Between HIV Infected Subjects and Their Main Heterosexual Partners. Hepat Mon 2013; 13: e13593 [PMID: 24348647 DOI: 10.5812/hepatmon.13593]
51. Rezaianzadeh A, Hasanzadeh J, Alipour A, Davarpanah MA, Rajaeifard A, Tabatabaee SH. Impact of hepatitis C on survival of HIV-infected individuals in Shiraz; South of Iran. Hepat Mon 2012; 12: 106-111 [PMID: 22509187 DOI: 10.5812/hepatmon.839]
52. Ramezani A, Banifazl M, Eslamifar A, Aghakhani A. Serological pattern of anti-HBc alone infers occult hepatitis B virus infection in high-risk individuals in Iran. J Infect Dev Ctries 2010; 4: 658-661 [PMID: 21045360]
53. Babamahmoodi F, Heidari Gorji MA, Mahdi Nasehi M, Delavarian L. The prevalence rate of hepatitis B and hepatitis C co-infection in HIV positive patients in Mazandaran province, Iran. Med Glas (Zenica) 2012; 9: 299-303 [PMID: 22926367]
54. Ataei B, Tayeri K, Kassaian N, Farajzadegan Z, Babak A. Hepatitis B and C among patients infected with human immunodeficiency virus in Isfahan, Iran: seroprevalence and associated factors. Hepat Mon 2010; 10: 188-192 [PMID: 22308138]
55. Mohammadi M, Talei G, Sheikhian A, Ebrahimzade F, Pournia Y, Ghasemi E, Boroun H. Survey of both hepatitis B virus (HBsAg) and hepatitis C virus (HCV-Ab) coinfection among HIV positive patients. Virol J 2009; 6: 202 [PMID: 19922624 DOI: 10.1186/1743-422x-6-202]
56. SeyedAlinaghi S, Jam S, Mehrkhani F, Fattahi F, Sabzvari D, Kourorian Z, Jabbari H, Mohraz M. Hepatitis-C and hepatitis-B co-infections in patients with human immunodeficiency virus in Tehran, Iran. Acta Med Iran 2011; 49: 252-257 [PMID: 21713737]
57. Alipour A, Rezaianzadeh A, Hasanzadeh J, Rajaeefard A, Davarpanah MA, Hasanabadi M. High prevalence of HCV coinfection in HIV-infected individuals in Shiraz, Islamic Republic of Iran. East Mediterr Health J 2013; 19: 975-981 [PMID: 24684094]
58. Rebbani K, Ouladlahsen A, Bensghir A, Akil A, Lamdini H, Issouf H, Brahim I, Kitab B, Fakhir FZ, Wakrim L, Marhoum El Filali K, Himmich H, Ezzikouri S, Benjelloun S. Co-infections with hepatitis B and C viruses in human immunodeficiency virusinfected patients in Morocco. Clin Microbiol Infect 2013; 19: E454-E457 [PMID: 23731409 DOI: 10.1111/1469-0691.12252]
59. Yousif M, Mudawi H, Hussein W, Mukhtar M, Nemeri O, Glebe D, Kramvis A. Genotyping and virological characteristics of hepatitis B virus in HIV-infected individuals in Sudan. Int J Infect Dis 2014; 29: 125-132 [PMID: 25449246 DOI: 10.1016/j.ijid.2014.07.002]
60. Aydin OA, Yemisen M, Karaosmanoglu HK, Sargin F, Gunduz A, Ceylan B, Mete B, Ozgunes N, Sevgi DY, Ozaras R, Tabak F. Low Prevalence of Hepatitis C Virus Infection Among HIV-Positive Patients: Data From a Large-Scale Cohort Study in Istanbul, Turkey. Hepat Mon 2014; 14: e18128 [PMID: 25337142 DOI: 10.5812/hepatmon.18128]
61. Altindis M, Yilmaz S, Dikengil T, Acemoglu H, Hosoglu S. Seroprevalence and genotyping of hepatitis B, hepatitis C and HIV among healthy population and Turkish soldiers in Northern Cyprus. World J Gastroenterol 2006; 12: 6792-6796 [PMID: 17106927]
62. Kafi-abad SA, Rezvan H, Abolghasemi H, Talebian A. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007. Transfusion 2009; 49: 2214-2220 [PMID: 19527477 DOI: 10.1111/j.1537-2995.2009.02245.x]
63. Mohammadali F, Pourfathollah AA. Changes in frequency of HBV, HCV, HIV and syphilis infections among blood donors in Tehran province 2005 - 2011. Arch Iran Med 2014; 17: 613-620 [PMID: 25204477]
64. Al Shaer L, AbdulRahman M, John TJ, AlHashimi A. Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009. Transfusion 2012; 52: 2300-2309 [PMID: 22691239 DOI: 10.1111/j.1537-2995.2012.03740.x]
65. Tahaei SM, Mohebbi SR, Azimzadeh P, Vahedi M, Almasi S, Romani S, Sharifian A, Derakhshan F, Zali MR. Frequency of HIV and HCV Co-Infections in Chronic HBV Patients Referred to Taleghani Hospital, Tehran, Iran from 2006 to 2010. Hepat Mon 2011; 11: 993-996 [PMID: 22368684 DOI: 10.5812/kowsar.1735143X.740]
66. Keramat F, Eini P, Majzoobi MM. Seroprevalence of HIV, HBV and HCV in Persons Referred to Hamadan Behavioral Counseling Center, West of Iran. Iran Red Crescent Med J 2011; 13: 42-46 [PMID: 22946017]
67. Daw MA, Shabash A, El-Bouzedi A, Dau AA. Seroprevalence of HBV, HCV&HIV co-infection and risk factors analysis in Tripoli-Libya. PLoS One 2014; 9: e98793 [PMID: 24936655 DOI: 10.1371/journal.pone.0098793]
68. Franka E, El-Zoka AH, Hussein AH, Elbakosh MM, Arafa AK, Ghenghesh KS. Hepatitis B virus and hepatitis C virus in medical waste handlers in Tripoli, Libya. J Hosp Infect 2009; 72: 258-261 [PMID: 19443080 DOI: 10.1016/j.jhin.2009.03.019]
69. Ozturk TC, Guneysel O, Tali A, Yildirim SE, Onur OE, Yaylaci S. Hepatitis B, Hepatitis C and HIV seroprevalence in critically ill emergency medicine department patients in a tertiary inner city hospital in Istanbul, Turkey. Pak J Med Sci 2014; 30: 703-707 [PMID: 25097500]
70. Turhanoglu M, Onur A, Bilman FB, Ayaydin Z, Aktar GS. Eightyear seroprevalence of HBV, HCV and HIV in Diyarbakir training and research hospital. Int J Med Sci 2013; 10: 1595-1601 [PMID: 24046538 DOI: 10.7150/ijms.6506]
71. Rotman Y, Liang TJ. Coinfection with hepatitis C virus and human immunodeficiency virus: virological, immunological, and clinical outcomes. J Virol 2009; 83: 7366-7374 [PMID: 19420073 DOI: 10.1128/jvi.00191-09]
72. Operskalski EA, Kovacs A. HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies. Curr HIV/AIDS Rep 2011; 8: 12-22 [PMID: 21221855 DOI: 10.1007/s11904-010-0071-3]
73. Beyrer C, Sullivan P, Sanchez J, Baral SD, Collins C, Wirtz AL, Altman D, Trapence G, Mayer K. The increase in global HIV epidemics in MSM. AIDS 2013; 27: 2665-2678 [PMID: 23842129 DOI: 10.1097/01.aids.0000432449.30239.fe]
74. Beyrer C, Baral SD, van Griensven F, Goodreau SM, Chariyalertsak S, Wirtz AL, Brookmeyer R. Global epidemiology of HIV infection in men who have sex with men. Lancet 2012; 380: 367-377 [PMID: 22819660 DOI: 10.1016/s0140-6736(12)60821-6]
75. Beyrer C, Wirtz AL, Walker D, Johns B, Sifakis F, Bara SD. The global HIV epidemics among men who have sex with men 2011. Available from: URL: http://siteresources.worldbank.org/INTHIVAIDS/Resources/375798-1103037153392/MSMReport.pdf
76. UNAIDS. UNAIDS Middle East and North Africa regional report on AIDS 2011. Available from: URL: http://www.unaids.org/sites/default/files/media_asset/JC2257_UNAIDS-MENA-report-2011_en_1.pdf
77. Tanser F, de Oliveira T, Maheu-Giroux M, Bärnighausen T. Concentrated HIV subepidemics in generalized epidemic settings. Curr Opin HIV AIDS 2014; 9: 115-125 [PMID: 24356328 DOI: 10.1097/coh.0000000000000034]
78. Baral SD, Friedman MR, Geibel S, Rebe K, Bozhinov B, Diouf D, Sabin K, Holland CE, Chan R, Cáceres CF. Male sex workers: practices, contexts, and vulnerabilities for HIV acquisition and transmission. Lancet 2015; 385: 260-273 [PMID: 25059939 DOI: 10.1016/s0140-6736(14)60801-1]
79. Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, Wodak A, Panda S, Tyndall M, Toufik A, Mattick RP. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet 2008; 372: 1733-1745 [PMID: 18817968 DOI: 10.1016/s0140-6736(08)61311-2]
80. Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D, Degenhardt L. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet 2011; 378: 571-583 [PMID: 21802134 DOI: 10.1016/s0140-6736(11)61097-0]
81. Mumtaz GR, Weiss HA, Thomas SL, Riome S, Setayesh H, Riedner G, Semini I, Tawil O, Akala FA, Wilson D, Abu-Raddad LJ. HIV among people who inject drugs in the Middle East and North Africa: systematic review and data synthesis. PLoS Med 2014; 11: e1001663 [PMID: 24937136 DOI: 10.1371/journal.pmed.1001663]
82. The Global State of Harm Reduction. Towards an integrated response 2012. Available from: URL: http://www.ihra.net/files/2012/07/24/GlobalState2012_Web.pdf
83. Stone K. The Global State of harm reduction 2014. Available from: URL: http://www.ihra.net/files/2015/02/16/GSHR2014.pdf
84. El-Bassel N, Wechsberg WM, Shaw SA. Dual HIV risk and vulnerabilities among women who use or inject drugs: no single prevention strategy is the answer. Curr Opin HIV AIDS 2012; 7: 326-331 [PMID: 22498480 DOI: 10.1097/COH.0b013e3283536ab2]